annual FCF:
$2.77B-$218.82M(-7.32%)Summary
- As of today (May 21, 2025), RPRX annual free cash flow is $2.77 billion, with the most recent change of -$218.82 million (-7.32%) on December 31, 2024.
- During the last 3 years, RPRX annual FCF has risen by +$751.45 million (+37.25%).
- RPRX annual FCF is now -7.32% below its all-time high of $2.99 billion, reached on December 31, 2023.
Performance
RPRX Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$596.08M-$146.45M(-19.72%)Summary
- As of today (May 21, 2025), RPRX quarterly free cash flow is $596.08 million, with the most recent change of -$146.45 million (-19.72%) on March 31, 2025.
- Over the past year, RPRX quarterly FCF has dropped by -$68.56 million (-10.32%).
- RPRX quarterly FCF is now -64.25% below its all-time high of $1.67 billion, reached on December 31, 2019.
Performance
RPRX quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$2.70B-$68.56M(-2.48%)Summary
- As of today (May 21, 2025), RPRX TTM free cash flow is $2.70 billion, with the most recent change of -$68.56 million (-2.48%) on March 31, 2025.
- Over the past year, RPRX TTM FCF has increased by +$81.82 million (+3.12%).
- RPRX TTM FCF is now -13.89% below its all-time high of $3.14 billion, reached on September 30, 2020.
Performance
RPRX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
RPRX Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.3% | -10.3% | +3.1% |
| 3 y3 years | +37.3% | +29.5% | +38.4% |
| 5 y5 years | +66.1% | +26.5% | +58.4% |
RPRX Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -7.3% | +37.3% | -42.3% | +29.5% | -9.6% | +38.4% |
| 5 y | 5-year | -7.3% | +66.1% | -42.3% | +29.5% | -13.9% | +58.4% |
| alltime | all time | -7.3% | +95.2% | -64.3% | +177.4% | -13.9% | >+9999.0% |
RPRX Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $596.08M(-19.7%) | $2.70B(-2.5%) |
| Dec 2024 | $2.77B(-7.3%) | $742.52M(+5.5%) | $2.77B(-1.1%) |
| Sep 2024 | - | $703.61M(+6.9%) | $2.80B(+4.9%) |
| Jun 2024 | - | $658.21M(-1.0%) | $2.67B(+1.9%) |
| Mar 2024 | - | $664.64M(-14.0%) | $2.62B(-12.4%) |
| Dec 2023 | $2.99B(+39.4%) | $772.63M(+34.7%) | $2.99B(+7.3%) |
| Sep 2023 | - | $573.52M(-5.6%) | $2.79B(+1.3%) |
| Jun 2023 | - | $607.82M(-41.2%) | $2.75B(+1.2%) |
| Mar 2023 | - | $1.03B(+81.4%) | $2.72B(+26.8%) |
| Dec 2022 | $2.14B(+6.3%) | $569.93M(+5.8%) | $2.14B(+3.9%) |
| Sep 2022 | - | $538.83M(-6.3%) | $2.06B(+3.5%) |
| Jun 2022 | - | $574.95M(+24.9%) | $1.99B(+2.2%) |
| Mar 2022 | - | $460.27M(-6.1%) | $1.95B(-3.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $2.02B(-0.8%) | $489.96M(+4.3%) | $2.02B(-3.6%) |
| Sep 2021 | - | $469.76M(-11.7%) | $2.09B(-1.8%) |
| Jun 2021 | - | $531.72M(+1.1%) | $2.13B(+2.0%) |
| Mar 2021 | - | $526.10M(-7.0%) | $2.09B(+2.7%) |
| Dec 2020 | $2.03B(+22.0%) | $565.67M(+11.2%) | $2.03B(-35.1%) |
| Sep 2020 | - | $508.85M(+4.1%) | $3.14B(+68.8%) |
| Jun 2020 | - | $489.00M(+3.8%) | $1.86B(+8.9%) |
| Mar 2020 | - | $471.10M(-71.7%) | $1.71B(+2.3%) |
| Dec 2019 | $1.67B(+3.0%) | $1.67B(-316.6%) | $1.67B(>+9900.0%) |
| Sep 2019 | - | -$769.78M(-328.6%) | $0.00(-100.0%) |
| Jun 2019 | - | $336.79M(-22.2%) | $769.78M(+77.8%) |
| Mar 2019 | - | $432.99M | $432.99M |
| Dec 2018 | $1.62B(+14.1%) | - | - |
| Dec 2017 | $1.42B | - | - |
FAQ
- What is Royalty Pharma annual free cash flow?
- What is the all time high annual FCF for Royalty Pharma?
- What is Royalty Pharma annual FCF year-on-year change?
- What is Royalty Pharma quarterly free cash flow?
- What is the all time high quarterly FCF for Royalty Pharma?
- What is Royalty Pharma quarterly FCF year-on-year change?
- What is Royalty Pharma TTM free cash flow?
- What is the all time high TTM FCF for Royalty Pharma?
- What is Royalty Pharma TTM FCF year-on-year change?
What is Royalty Pharma annual free cash flow?
The current annual FCF of RPRX is $2.77B
What is the all time high annual FCF for Royalty Pharma?
Royalty Pharma all-time high annual free cash flow is $2.99B
What is Royalty Pharma annual FCF year-on-year change?
Over the past year, RPRX annual free cash flow has changed by -$218.82M (-7.32%)
What is Royalty Pharma quarterly free cash flow?
The current quarterly FCF of RPRX is $596.08M
What is the all time high quarterly FCF for Royalty Pharma?
Royalty Pharma all-time high quarterly free cash flow is $1.67B
What is Royalty Pharma quarterly FCF year-on-year change?
Over the past year, RPRX quarterly free cash flow has changed by -$68.56M (-10.32%)
What is Royalty Pharma TTM free cash flow?
The current TTM FCF of RPRX is $2.70B
What is the all time high TTM FCF for Royalty Pharma?
Royalty Pharma all-time high TTM free cash flow is $3.14B
What is Royalty Pharma TTM FCF year-on-year change?
Over the past year, RPRX TTM free cash flow has changed by +$81.82M (+3.12%)